KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jun 20, 2025 >>  ABB India 5968.7  [ 1.76% ]  ACC 1823.95  [ -0.08% ]  Ambuja Cements 533.5  [ 0.09% ]  Asian Paints Ltd. 2284.95  [ 0.73% ]  Axis Bank Ltd. 1220.15  [ 0.23% ]  Bajaj Auto 8369.4  [ -1.49% ]  Bank of Baroda 234.25  [ 1.12% ]  Bharti Airtel 1936.95  [ 3.27% ]  Bharat Heavy Ele 250.4  [ 1.36% ]  Bharat Petroleum 313.4  [ 0.03% ]  Britannia Ind. 5588.25  [ 0.66% ]  Cipla 1500.5  [ 1.17% ]  Coal India 388.85  [ 1.18% ]  Colgate Palm. 2401.7  [ 0.12% ]  Dabur India 466.7  [ 0.33% ]  DLF Ltd. 854.4  [ 1.79% ]  Dr. Reddy's Labs 1325.45  [ -0.07% ]  GAIL (India) 181.8  [ 0.89% ]  Grasim Inds. 2712.55  [ 0.79% ]  HCL Technologies 1739.75  [ 1.51% ]  HDFC Bank 1965.7  [ 1.60% ]  Hero MotoCorp 4340.6  [ -1.01% ]  Hindustan Unilever L 2304.9  [ 0.47% ]  Hindalco Indus. 649.05  [ 1.18% ]  ICICI Bank 1427.35  [ 1.13% ]  Indian Hotels Co 764.35  [ 2.32% ]  IndusInd Bank 840.3  [ 0.33% ]  Infosys L 1621.85  [ 0.21% ]  ITC Ltd. 418.45  [ 0.59% ]  Jindal St & Pwr 899.95  [ 1.12% ]  Kotak Mahindra Bank 2169.45  [ 1.13% ]  L&T 3660.65  [ 1.12% ]  Lupin Ltd. 1946.75  [ 0.74% ]  Mahi. & Mahi 3182.3  [ 2.93% ]  Maruti Suzuki India 12806.15  [ 0.00% ]  MTNL 47.63  [ 0.78% ]  Nestle India 2364.65  [ 1.97% ]  NIIT Ltd. 125.9  [ -1.49% ]  NMDC Ltd. 67.94  [ 1.36% ]  NTPC 335.35  [ 1.70% ]  ONGC 251.85  [ 0.12% ]  Punj. NationlBak 103.1  [ 0.15% ]  Power Grid Corpo 293.1  [ 2.38% ]  Reliance Inds. 1464.65  [ 2.16% ]  SBI 796  [ 1.44% ]  Vedanta 446.95  [ 1.70% ]  Shipping Corpn. 219.45  [ 1.97% ]  Sun Pharma. 1664  [ 1.01% ]  Tata Chemicals 913.8  [ 0.56% ]  Tata Consumer Produc 1099.8  [ 1.08% ]  Tata Motors 676.1  [ 0.58% ]  Tata Steel 151.9  [ 0.63% ]  Tata Power Co. 389.7  [ 1.34% ]  Tata Consultancy 3434.35  [ 0.29% ]  Tech Mahindra 1696.4  [ 0.80% ]  UltraTech Cement 11443.15  [ 0.31% ]  United Spirits 1458.75  [ -0.15% ]  Wipro 266.35  [ 0.32% ]  Zee Entertainment En 132.95  [ 4.19% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    GLENMARK PHARMACEUTICALS LTD.

    20 June 2025 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE935A01035 BSE Code / NSE Code 532296 / GLENMARK Book Value (Rs.) 299.28 Face Value 1.00
    Bookclosure 27/09/2024 52Week High 1831 EPS 37.10 P/E 44.11
    Market Cap. 46187.81 Cr. 52Week Low 1199 P/BV / Div Yield (%) 5.47 / 0.15 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202503(3) 202412(3) 202503(3) 202412(3)
    OprtIncome Glenmark Pharmaceuticals Ltd. 2009.49 2251.28 Aarey Drugs & Pharmaceuticals Ltd. 108.10 133.79
    OtherRecurrInc Glenmark Pharmaceuticals Ltd. 88.45 129.19 Aarey Drugs & Pharmaceuticals Ltd. 7.54 0.68
    Operating profit Glenmark Pharmaceuticals Ltd. 285.00 438.76 Aarey Drugs & Pharmaceuticals Ltd. -3.43 1.62
    GrossProfit Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Glenmark Pharmaceuticals Ltd. 147.76 413.80 Aarey Drugs & Pharmaceuticals Ltd. 0.47 0.72
    Equity Capital Glenmark Pharmaceuticals Ltd. 28.22 28.22 Aarey Drugs & Pharmaceuticals Ltd. 28.05 28.05
    OPM Glenmark Pharmaceuticals Ltd. 14.18 19.48 Aarey Drugs & Pharmaceuticals Ltd. -3.17 1.21
    GPM Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Glenmark Pharmaceuticals Ltd. 7.35 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.43 0.53

    Annual Trends

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202503(12) 202403(12) 202503(12) 202403(12)
    OperatingIncome Glenmark Pharmaceuticals Ltd. 9226.41 7891.12 Aarey Drugs & Pharmaceuticals Ltd. 473.94 395.62
    OperatingProfit Glenmark Pharmaceuticals Ltd. 2244.18 1241.66 Aarey Drugs & Pharmaceuticals Ltd. 2.25 4.45
    OtherRecurrInc Glenmark Pharmaceuticals Ltd. 356.37 1168.02 Aarey Drugs & Pharmaceuticals Ltd. 9.81 6.96
    AdjustedPBT Glenmark Pharmaceuticals Ltd. 2333.18 1930.42 Aarey Drugs & Pharmaceuticals Ltd. 6.10 5.34
    ReportedPAT Glenmark Pharmaceuticals Ltd. 1610.35 5167.29 Aarey Drugs & Pharmaceuticals Ltd. 4.02 4.68
    EquityDividend Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Glenmark Pharmaceuticals Ltd. 28.22 28.22 Aarey Drugs & Pharmaceuticals Ltd. 28.05 28.05
    PreferenceCapital Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Glenmark Pharmaceuticals Ltd. 24475.74 22939.88 Aarey Drugs & Pharmaceuticals Ltd. 110.43 102.25
    LoanFunds Glenmark Pharmaceuticals Ltd. 698.82 657.24 Aarey Drugs & Pharmaceuticals Ltd. 34.86 31.35
    AL_CurrentLiabilities Glenmark Pharmaceuticals Ltd. 2830.50 3786.54 Aarey Drugs & Pharmaceuticals Ltd. 64.93 139.17
    NetBlock Glenmark Pharmaceuticals Ltd. 2133.74 1756.24 Aarey Drugs & Pharmaceuticals Ltd. 18.34 12.96
    Investments Glenmark Pharmaceuticals Ltd. 15194.91 12964.79 Aarey Drugs & Pharmaceuticals Ltd. 0.00 1.38
    TotCurrentAssets Glenmark Pharmaceuticals Ltd. 10704.64 12495.69 Aarey Drugs & Pharmaceuticals Ltd. 219.93 288.95

    Ratios

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202503(12) 202403(12) 202503(12) 202403(12)
    OPM Glenmark Pharmaceuticals Ltd. 24.32 15.73 Aarey Drugs & Pharmaceuticals Ltd. 0.47 1.12
    NPM Glenmark Pharmaceuticals Ltd. 17.45 65.48 Aarey Drugs & Pharmaceuticals Ltd. 0.84 1.18
    Reported EPS Glenmark Pharmaceuticals Ltd. 57.07 183.13 Aarey Drugs & Pharmaceuticals Ltd. 1.43 1.67
    Return on Networth Glenmark Pharmaceuticals Ltd. 6.57 22.49 Aarey Drugs & Pharmaceuticals Ltd. 2.90 3.59
    Debt/ Equity Glenmark Pharmaceuticals Ltd. 0.02 0.02 Aarey Drugs & Pharmaceuticals Ltd. 0.25 0.24
    Financial Charges Coverage Ratio Glenmark Pharmaceuticals Ltd. 53.36 8.70 Aarey Drugs & Pharmaceuticals Ltd. 3.00 2.61
    Current Ratio Glenmark Pharmaceuticals Ltd. 3.78 3.30 Aarey Drugs & Pharmaceuticals Ltd. 3.39 2.08
    Dividend per share Glenmark Pharmaceuticals Ltd. 2.50 2.50 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.